Immix Biopharma, Inc.
IMMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873835
No open-market purchases or sales by Immix Biopharma, Inc. insiders were filed in the last 90 days; 109 institutions reported holding it in 13F filings for Q2 2026, worth $579.6M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Immix Biopharma, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- +8 vs. Q2 2025
- Shares held
- 2.77M
- +503.7K (+22.3%) vs. Q2 2025
- Total value
- $5.78M
- +$1.10M (+23.5%) vs. Q2 2025
- New holders
- 12
- 7 more added
- Sold out
- 4
- 4 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMMX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 109 | $579.6M |
| Q1 2026 | 77 | $246.6M |
| Q4 2025 | 67 | $127.5M |
| Q3 2025 | 31 | $5.78M |
| Q2 2025 | 23 | $4.68M |
| Q1 2025 | 22 | $4.90M |
| Q4 2024 | 23 | $6.32M |
| Q3 2024 | 25 | $6.10M |
| Q2 2024 | 31 | $8.77M |
| Q1 2024 | 35 | $15.7M |
| Q4 2023 | 28 | $5.32M |
| Q3 2023 | 16 | $1.39M |
| Q2 2023 | 18 | $1.75M |
| Q1 2023 | 12 | $729.8K |
| Q4 2022 | 18 | $1.01M |
| Q3 2022 | 12 | $406.0K |
| Q2 2022 | 7 | $475.0K |
| Q1 2022 | 8 | $352.0K |
| Q4 2021 | 11 | $5.47M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Immix Biopharma, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bleichroeder LP | 850,000 | $1.78M | 0.35% | 00.0% | Unchanged |
| Vanguard Group Inc | 730,162 | $1.53M | 0.00% | +31,625+4.5% | Added |
| Geode Capital Management, LLC | 187,476 | $391.9K | 0.00% | +26,361+16.4% | Added |
| Morgan Stanley | 120,670 | $252.2K | 0.00% | −4,249−3.4% | Reduced |
| State Street Corp | 98,960 | $206.8K | 0.00% | +56,000+130.4% | Added |
| Susquehanna International Group, LLP | 90,858 | $189.9K | 0.00% | +40,032+78.8% | Added |
| Citadel Advisors LLC | 89,798 | $187.7K | 0.00% | +89,798 | New |
| Northern Trust Corp | 89,301 | $186.6K | 0.00% | −4,587−4.9% | Reduced |
| United Capital Financial Advisers, LLC | 70,682 | $147.7K | 0.00% | +70,682 | New |
| Imprint Wealth LLC | 67,423 | $140.9K | 0.45% | +67,423 | New |
| Marshall Wace, LLP | 55,035 | $115.0K | 0.00% | +55,035 | New |
| BlackRock, Inc. | 43,068 | $90.0K | 0.00% | +2,767+6.9% | Added |
| Tocqueville Asset Management L.P. | 40,250 | $84.1K | 0.00% | +10,950+37.4% | Added |
| XTX Topco Ltd | 35,153 | $73.5K | 0.00% | +35,153 | New |
| Velan Capital Investment Management LP | 35,000 | $73.2K | 0.07% | +10,000+40.0% | Added |
| Private Advisor Group, LLC | 31,225 | $65.3K | 0.00% | 00.0% | Unchanged |
| Tritonpoint Wealth, LLC | 24,526 | $51.3K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 21,500 | $44.9K | 0.00% | +21,500 | New |
| SBI Securities Co., Ltd. | 17,500 | $36.6K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 16,040 | $34.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 14,970 | $31.3K | 0.00% | +14,970 | New |
| Colony Group, LLC | 11,900 | $24.9K | 0.00% | 00.0% | Unchanged |
| CIBC Private Wealth Group, LLC | 10,000 | $20.9K | 0.00% | +10,000 | New |
| Snowden Capital Advisors LLC | 10,000 | $20.9K | 0.00% | +10,000 | New |
| MAI Capital Management | 2,000 | $4.18K | 0.00% | +2,000 | New |
| UBS Group AG | 1,940 | $4.05K | 0.00% | −12,032−86.1% | Reduced |
| Wells Fargo & Company | 330 | $690 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 80 | $167 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 35 | $73 | 0.00% | +35 | New |
| SRS Capital Advisors, Inc. | 34 | $71 | 0.00% | +34 | New |
| Bank of America Corp | 12 | $25 | 0.00% | −127−91.4% | Reduced |
| Virtu Financial LLC | 0 | $0 | 0.00% | −17,846−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −11,168−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −525−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −131−100.0% | Sold out |